"The cat is out of the bag." -- Adam Waickman, PhD, of SUNY Upstate Medical University in Syracuse, New York, discussing the ...

Heart attacks are largely preventable, and we have had the means to find the disease and treat it in time for more than a ...

Until recently, a Manhattanite might venture no more than a few dozen blocks to find the world's most sophisticated cancer ...

Significant proteinuria reductions were reported in phase III interim analyses assessing two investigational IgA nephropathy ...

Tennessee execution team members failed multiple times to establish working IV lines in Christa Pike's arms before her attempted execution and warned that some of her veins may have ruptured, or ...

Overall survival (OS) in extensive-stage small-cell lung cancer (ES-SCLC) approached 2 years with tarlatamab (Imdelltra) combination maintenance therapy after first-line chemoimmunotherapy, a large ...

Perioperative treatment with durvalumab (Imfinzi) plus neoadjuvant enfortumab vedotin (EV) significantly improved event-free survival (EFS) and overall survival (OS) compared with radical cystectomy ...

Treatment with SGLT2 inhibitors was linked with modest but statistically significant increases in hemoglobin and hematocrit levels across a broad spectrum of patient populations, according to a ...

In the Breakfree-2 study, one death occurred due to septic pneumonia after a participant received high-dose cyclophosphamide, reported Jeffrey Cohen, MD, of the Cleveland Clinic Mellen Center.

Atacicept and sibeprenlimab were granted accelerated FDA approval based on interim trial findings that showed a reduction in proteinuria in adults with IgA nephropathy. As a condition of the ...